Search results
Bath Savings Trust Co Acquires 196 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoBath Savings Trust Co increased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.0% during the 1st quarter, according to its most recent Form 13F filing ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Michael S. Ryan Inc.
ETF DAILY NEWS· 5 days agoMichael S. Ryan Inc. lowered its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.6% in the first quarter, according to its most recent disclosure with the SEC. The ...
Cardinal Capital Management Inc. Sells 3,561 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoCardinal Capital Management Inc. cut its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the 1st quarter, according to the company in its most recent ...
Beese Fulmer Investment Management Inc. Cuts Stock Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoBeese Fulmer Investment Management Inc. reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.6% during the first quarter, Holdings Channel.com reports. The institutional ...
American National Bank Acquires 1,816 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoAmerican National Bank grew its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% during the first quarter, according to its most recent filing with the ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 4 days agoOn June 20, 2024, AbbVie Inc. (NYSE:ABBV) announced that it has received FDA approval for expanding the use of its interleukin-23 (IL-23) inhibitor, Skyrizi, to treat adults ...
GAMMA Investing LLC Has $3.53 Million Stock Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 4 days agoGAMMA Investing LLC boosted its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 18.9% during the first quarter, according to the company in its most recent filing with the ...
As AbbVie Drug Gets FDA Nod, Traders Can Look Up to These Targets
TheStreet.com· 4 days agoAbbVie (ABBV) on Wednesday won Food and Drug Administration approval for a new use for its drug...
Walden Wealth Partners LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 6 days agoWalden Wealth Partners LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F ...
AbbVie says FDA approves Skyrizi for ulcerative colitis
Market Watch· 5 days agoDrug maker AbbVie Inc. on Tuesday said the Food and Drug Administration had approved its drug...